Agios Pharmaceuticals Inc Beta
Mi az Agios Pharmaceuticals Inc Beta?
A Beta az Agios Pharmaceuticals Inc - 1.08
Mi a Beta meghatározása?
A BETA azt jelzi, hogy az állomány több-kevésbé volatilis, mint a piac egésze. Az 1-nél kevesebb béta azt jelzi, hogy az állomány kevésbé ingadozó, mint a piac, míg az 1-nél nagyobb béta azt jelzi, hogy az állomány volatilisabb. A volatilitást az átlag körüli ár ingadozásaként méri.
Beta is a measure of the risk arising from exposure to general market movements as opposed to idiosyncratic factors. The market portfolio of all investable assets has a beta of exactly 1. A beta below 1 can indicate either an investment with lower volatility than the market, or a volatile investment whose price movements are not highly correlated with the market. A beta greater than one generally means that the asset both is volatile and tends to move up and down with the market. Beta is important because it measures the risk of an investment that cannot be reduced by diversification. It does not measure the risk of an investment held on a stand-alone basis, but the amount of risk the investment adds to an already-diversified portfolio. In the capital asset pricing model, beta risk is the only kind of risk for which investors should receive an expected return higher than the risk-free rate of interest.
Beta a Health Care szektor a NASDAQ-on cégekben a Agios Pharmaceuticals Inc -hoz képest
Mit csinál Agios Pharmaceuticals Inc?
at agios, we are doing incredibly important and difficult work. we are trying to discover and develop breakthrough medicines, and we have a clear motivator — people with cancer and rare genetic diseases who are counting on us to be successful. we are a science-driven research organization. we have built a discovery platform upon our expertise in the fields of cellular metabolism and precision medicine across three major focus areas: cancer metabolism, rare genetic metabolic disorders and metabolic immuno-oncology. it takes people with a diversity of thought, skills, passions and backgrounds to get us from the first stages of understanding new biology and discovering drugs to our ultimate goal of getting these medicines to patients who are waiting for them. our connection to one another and our work and our commitment to our values enable us to potentially change the practice of medicine by by striving for excellence and doing things differently. we call this the "other side of possible
beta -hoz hasonló cégek Agios Pharmaceuticals Inc
- Simmons First National nak Beta 1.08 van
- BTCS nak Beta 1.08 van
- Annaly Capital Management Inc nak Beta 1.08 van
- Pan American Silver nak Beta 1.08 van
- Lovable Lingerie nak Beta 1.08 van
- Town Centre Securities PLC nak Beta 1.08 van
- Agios Pharmaceuticals Inc nak Beta 1.08 van
- The Sherwin-Williams nak Beta 1.08 van
- Euronet Worldwide Inc nak Beta 1.08 van
- Rockwealth Resources nak Beta 1.08 van
- Pan Orient nak Beta 1.08 van
- Pan Orient nak Beta 1.08 van
- The Karur Vysya Bank nak Beta 1.08 van